Commercializing cell & gene therapies
If the full potential of cell and gene therapies is to be realised their production must scale. At the heart of this challenge is the need to design an automated, repeatable and compliant process for generating and testing large volumes of cells to ensure they are a safe and effective therapy. Designing scalable approaches to quality control and release testing is an essential part of this and a key issue for many of our clients.
Cell & gene therapy scale-up
We are experienced in developing high throughput, commercial and large-scale manufacturing processes applicable to cell & gene therapies.
We have an in-depth understanding of fluid mechanics coupled with practical knowledge of fluid handling technologies.
Delivering products which meet requirements and production timescales, provide a satisfying user experience, and are suitable for manufacture, maintainable and profitable.
Designing for cost, space, power requirements, environmental conditions, reliability, usability and manufacturing process.
Developing a product to meet a price point. We understand the different components that contribute to overall cost and can advise on where to focus to gain cost reductions.
Sagentia offers a unique blend of core skills, facilitating progress and innovation.
